bluebird bio Inc. (BLUE)
bluebird bio Statistics
Share Statistics
bluebird bio has 9.74M shares outstanding. The number of shares has increased by 0.88% in one year.
| Shares Outstanding | 9.74M |
| Shares Change (YoY) | 0.88% |
| Shares Change (QoQ) | 0.27% |
| Owned by Institutions (%) | 32.16% |
| Shares Floating | 9.63M |
| Failed to Deliver (FTD) Shares | 212 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 47.71M, so 490.69% of the outstanding shares have been sold short.
| Short Interest | 47.71M |
| Short % of Shares Out | 490.69% |
| Short % of Float | 495.04% |
| Short Ratio (days to cover) | 9.53 |
Valuation Ratios
The PE ratio is -14.3 and the forward PE ratio is -0.76. bluebird bio's PEG ratio is 0.33.
| PE Ratio | -14.3 |
| Forward PE | -0.76 |
| PS Ratio | 102.76 |
| Forward PS | 0.1 |
| PB Ratio | 15.58 |
| P/FCF Ratio | -12.42 |
| PEG Ratio | 0.33 |
Enterprise Valuation
bluebird bio Inc. has an Enterprise Value (EV) of 712.19M.
| EV / Earnings | -3.36 |
| EV / Sales | 24.14 |
| EV / EBITDA | -4.26 |
| EV / EBIT | -2.92 |
| EV / FCF | -2.92 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 1.7.
| Current Ratio | 1.41 |
| Quick Ratio | 1.29 |
| Debt / Equity | 1.7 |
| Total Debt / Capitalization | 62.94 |
| Cash Flow / Debt | -0.71 |
| Interest Coverage | -14.94 |
Financial Efficiency
Return on equity (ROE) is -1.09% and return on capital (ROIC) is -46.51%.
| Return on Equity (ROE) | -1.09% |
| Return on Assets (ROA) | -0.34% |
| Return on Capital (ROIC) | -46.51% |
| Revenue Per Employee | $104,599.29 |
| Profits Per Employee | $-751,464.54 |
| Employee Count | 282 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 1.46 |
Taxes
| Income Tax | -126K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -87.25% in the last 52 weeks. The beta is 0.82, so bluebird bio's price volatility has been higher than the market average.
| Beta | 0.82 |
| 52-Week Price Change | -87.25% |
| 50-Day Moving Average | 7.32 |
| 200-Day Moving Average | 12.6 |
| Relative Strength Index (RSI) | 27.78 |
| Average Volume (20 Days) | 500.48K |
Income Statement
In the last 12 months, bluebird bio had revenue of 29.5M and earned -211.91M in profits. Earnings per share was -1.93.
| Revenue | 29.5M |
| Gross Profit | -4.03M |
| Operating Income | -244.26M |
| Net Income | -211.91M |
| EBITDA | -167.16M |
| EBIT | -244.26M |
| Earnings Per Share (EPS) | -1.93 |
Balance Sheet
The company has 221.75M in cash and 330.33M in debt, giving a net cash position of -108.57M.
| Cash & Cash Equivalents | 221.75M |
| Total Debt | 330.33M |
| Net Cash | -108.57M |
| Retained Earnings | -4.26B |
| Total Assets | 465.06M |
| Working Capital | -145.22M |
Cash Flow
In the last 12 months, operating cash flow was -235.05M and capital expenditures -9.06M, giving a free cash flow of -244.1M.
| Operating Cash Flow | -235.05M |
| Capital Expenditures | -9.06M |
| Free Cash Flow | -244.1M |
| FCF Per Share | -2.22 |
Margins
Gross margin is -13.66%, with operating and profit margins of -828.09% and -718.42%.
| Gross Margin | -13.66% |
| Operating Margin | -828.09% |
| Pretax Margin | -718.85% |
| Profit Margin | -718.42% |
| EBITDA Margin | -566.71% |
| EBIT Margin | -828.09% |
| FCF Margin | -827.55% |
Dividends & Yields
BLUE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -49.49% |
| FCF Yield | -642.55% |
Analyst Forecast
The average price target for BLUE is $33.6, which is 761.5% higher than the current price. The consensus rating is "Hold".
| Price Target | $33.6 |
| Price Target Difference | 761.5% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
Stock Splits
The last stock split was on Dec 13, 2024. It was a backward split with a ratio of 1:20.
| Last Split Date | Dec 13, 2024 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -15.1 |
| Piotroski F-Score | 2 |